Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
about
Atrial high-rate episodes and stroke prevention.Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care.ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives.Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective.Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment.Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience.Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience.
P2860
Q33589724-46001C0A-3623-419D-8EB1-328A044FC0B0Q37312543-849181FE-8604-4346-ACDC-BAC54F9656A7Q38650658-3BFCF44B-33CE-451B-BC58-6516CE7C003BQ38663427-178D0D2C-B1DA-4E89-93D1-9B62D7D67BE3Q42706796-BF5ACDCD-CA65-466B-B534-EA378168D168Q45974877-3ED27DD7-AF49-4944-989C-BED0340FA6C9Q47153532-5FDFB796-E77F-4BC9-BE34-2FC546D83A99Q48578606-BC2B2B5F-5617-4D0E-8D93-AF2302158166Q53345937-B19C0500-0D8E-404C-9EF4-B2C8BD7B46D1Q54511916-CBB57142-FEC4-4AEA-AC71-D281BBF15032
P2860
Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Non-vitamin K antagonist oral ...... ies for optimal implementation
@ast
Non-vitamin K antagonist oral ...... ies for optimal implementation
@en
Non-vitamin K antagonist oral ...... ies for optimal implementation
@nl
type
label
Non-vitamin K antagonist oral ...... ies for optimal implementation
@ast
Non-vitamin K antagonist oral ...... ies for optimal implementation
@en
Non-vitamin K antagonist oral ...... ies for optimal implementation
@nl
prefLabel
Non-vitamin K antagonist oral ...... ies for optimal implementation
@ast
Non-vitamin K antagonist oral ...... ies for optimal implementation
@en
Non-vitamin K antagonist oral ...... ies for optimal implementation
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Non-vitamin K antagonist oral ...... ies for optimal implementation
@en
P2093
A. John Camm
F.D. Richard Hobbs
Felicita Andreotti
Graeme J. Hankey
P2860
P304
P3181
P356
10.1093/EUROPACE/EUV068
P407
P50
P5008
P577
2015-07-01T00:00:00Z